Does living donation have advantages over deceased donation in liver transplantation?

Journal of Gastroenterology and Hepatology (Australia)

Volumn 25, Issue 10, 2010, Pages 1598-1603

  Kaido, Toshimi ^a   Uemoto, Shinji ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

deceased donor liver transplantation; donor complication; expanded criteria; hepatocellular carcinoma; living donor liver transplantation

Indexed keywords

CANCER RECURRENCE; CANCER SURGERY; COMPARATIVE STUDY; HUMAN; LIVER CELL CARCINOMA; LIVER TRANSPLANTATION; LIVING DONOR; PRIORITY JOURNAL; REVIEW; TREATMENT OUTCOME; CANCER SURVIVAL; COLD ISCHEMIA; GRAFT RECIPIENT; INTENTION TO TREAT ANALYSIS; MORBIDITY; MORTALITY; PREOPERATIVE PERIOD;

EID: 77957601720     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2010.06418.x     Document Type: Review

References (48)

1. Ringe B, Strong RW. The dilemma of living liver donor death: to report or not to report? Transplantation 2008 85 : 790 793.
2. Shaked A, Ghobrial RM, Merion RM et al. Incidence and severity of acute cellular rejection in recipients undergoing adult living donor or deceased donor liver transplantation. Am. J. Transplant. 2009 9 : 301 308.
3. Reese PP, Sonawane SB, Thomasson A, Yeh H, Markmann JF. Donor age and cold ischemia interact to produce inferior 90-day liver allograft survival. Transplantation 2008 85 : 1737 1744.
4. Mazzaferro V, Regalia E, Doci R et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N. Engl. J. Med. 1996 334 : 693 699.
5. Maddala YK, Stadheim L, Andrews JC et al. Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: outcome with chemoembolization. Liver Transpl. 2004 10 : 449 455.
6. Brown RS Jr. Live donors in liver transplantation. Gastroenterology 2008 134 : 1802 1813.
7. Cheng SJ, Pratt DS, Freeman RB Jr., Kaplan MM, Wong JB. Living-donor versus cadaveric liver transplantation for non-resectable small hepatocellular carcinoma and compensated cirrhosis: a decision analysis. Transplantation 2001 72 : 861 868.
8. Sarasin FP, Majno PE, Llovet JM, Bruix J, Mentha G, Hadengue A. Living donor liver transplantation for early hepatocellular carcinoma: a life-expectancy and cost-effectiveness perspective. Hepatology 2001 33 : 1073 1079.
9. Lo CM, Fan ST, Liu CL, Chan SC, Wong J. The role and limitation of living donor liver transplantation for hepatocellular carcinoma. Liver Transpl. 2004 10 : 440 447.
10. Fisher RA, Kulik LM, Freise CE et al. A2ALL Study Group. Hepatocellular carcinoma recurrence and death following living and deceased donor liver transplantation. Am. J. Transplant. 2007 7 : 1601 1608.
11. Lo CM, Fan ST, Liu CL, Chan SC, Ng IO, Wong J. Living donor versus deceased donor liver transplantation for early irresectable hepatocellular carcinoma. Br. J. Surg. 2007 94 : 78 86.
12. Ninomiya M, Harada N, Shiotani S et al. Hepatocyte growth factor and transforming growth factor beta1 contribute to regeneration of small-for-size liver graft immediately after transplantation. Transpl. Int. 2003 16 : 814 819.
13. Di Sandro S, Slim AO, Giacomoni A et al. Living donor liver transplantation for hepatocellular carcinoma: long-term results compared with deceased donor liver transplantation. Transplant. Proc. 2009 41 : 1283 1285.
14. Yao FY, Ferrell L, Bass NM et al. Liver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survival. Hepatology 2001 33 : 1394 1403.
15. Yao FY, Xiao L, Bass NM, Kerlan R, Ascher NL, Roberts JP. Liver transplantation for hepatocellular carcinoma: validation of the UCSF-expanded criteria based on preoperative imaging. Am. J. Transplant. 2007 7 : 2587 2596.
16. Decaens T, Roudot-Thoraval F, Hadni-Bresson S et al. Impact of UCSF criteria according to pre- and post-OLT tumor features: analysis of 479 patients listed for HCC with a short waiting time. Liver Transpl. 2006 12 : 1761 1769.
17. Toso C, Asthana S, Bigam DL, Shapiro AM, Kneteman NM. Reassessing selection criteria prior to liver transplantation for hepatocellular carcinoma utilizing the Scientific Registry of Transplant Recipients database. Hepatology 2009 49 : 832 838.
18. Sotiropoulos GC, Lang H, Sgourakis G et al. Liberal policy in living donor liver transplantation for hepatocellular carcinoma: lessons learned. Dig. Dis. Sci. 2009 54 : 377 384.
19. Kaihara S, Kiuchi T, Ueda M et al. Living-donor liver transplantation for hepatocellular carcinoma. Transplantation 2003 75 : S37 40.
20. Takada Y, Ito T, Ueda M et al. Living donor liver transplantation for patients with HCC exceeding the Milan criteria: a proposal of expanded criteria. Dig. Dis. 2007 25 : 299 302.
21. Ito T, Takada Y, Ueda M et al. Expansion of selection criteria for patients with hepatocellular carcinoma in living donor liver transplantation. Liver Transpl. 2007 13 : 1637 1644.
22. Kaido T, Takada Y, Uemoto S. Selection criteria for patients with hepatocellular carcinoma in liver transplantation. Transplantation 2009 88 : 442 443.
23. Kaido T, Takada Y, Uemoto S. Usefulness of Kyoto criteria as selection criteria for living donor liver transplantation for hepatocellular carcinoma. Liver Transpl. 2010 16 : 538 40.
24. Soejima Y, Taketomi A, Yoshizumi T et al. Extended indication for living donor liver transplantation in patients with hepatocellular carcinoma. Transplantation 2007 83 : 893 899.
25. Zheng SS, Xu X, Wu J et al. Liver transplantation for hepatocellular carcinoma: Hangzhou experiences. Transplantation 2008 85 : 1726 1732.
26. Lee SG, Hwang S, Moon DB et al. Expanded indication criteria of living donor liver transplantation for hepatocellular carcinoma at one large-volume center. Liver Transpl. 2008 14 : 935 945.
27. Todo S, Furukawa H, Tada M, Japanese Liver Transplantation Study Group. Extending indication: role of living donor liver transplantation for hepatocellular carcinoma. Liver Transpl. 2007 13 : S48 54.
28. Selzner M, Kashfi A, Cattral MS et al. A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation. Liver Transpl. 2009 15 : 1776 1782.
29. Thuluvath PJ, Yoo HY. Graft and patient survival after adult live donor liver transplantation compared to a matched cohort who received a deceased donor transplantation. Liver Transpl. 2004 10 : 1263 1268.
30. Lee KW, Cameron AM, Maley WR, Segev DL, Montgomery RA. Factors affecting graft survival after adult/child split-liver transplantation: analysis of the UNOS/OPTN data base. Am. J. Transplant. 2008 8 : 1186 1196.
31. Pikul J, Sharpe MD, Lowndes R, Ghent CN. Degree of preoperative malnutrition is predictive of postoperative morbidity in liver transplant recipients. Transplantation 1994 57 : 469 472.
32. Selberg O, Böttcher J, Tusch G, Pichlmayr R, Henkel E, Müller MJ. Identification of high-and low-risk patients before liver transplantation: a prospective cohort study of nutritional and metabolic parameters in 150 patients. Hepatology 1997 25 : 652 657.
33. Sanchez AJ, Aranda-Michel J. Nutrition for the liver transplant patient. Liver Transpl. 2006 12 : 1310 1316.
34. Stickel F, Inderbitzin D, Candinas D. Role of nutrition in liver transplantation for end-stage chronic liver disease. Nutr. Rev. 2008 66 : 47 54.
35. Kaido T, Egawa H, Tsuji H, Ashihara E, Maekawa T, Uemoto S. In-hospital mortality in adult recipients of living donor liver transplantation: experience of 576 consecutive cases at a single center. Liver Transpl. 2009 15 : 1420 1425.
36. Plank LD, McCall JL, Gane EJ et al. Pre- and postoperative immunonutrition in patients undergoing liver transplantation: a pilot study of safety and efficacy. Clin. Nutr. 2005 24 : 288 296.
37. Nickkholgh A, Schneider H, Encke J, Büchler MW, Schmidt J, Schemmer P. PROUD: effects of preoperative long-term immunonutrition in patients listed for liver transplantation. Trials 2007 8 : 20.
38. Weimann A, Braga M, Harsanyi L et al. ESPEN guidelines on enteral nutrition: surgery including organ transplantation. Clin. Nutr. 2006 25 : 224 244.
39. Kaido T, Mori A, Oike F et al. Impact of pretransplant nutritional status in patients undergoing liver transplantation. Hepatogastroenterelogy 2010 (in press).
40. Hwang S, Lee SG, Jang SJ et al. The effect of donor weight reduction on hepatic steatosis for living donor liver transplantation. Liver Transpl. 2004 10 : 721 725.
41. Sugawara Y, Makuuchi M, Matsui Y et al. Preemptive therapy for hepatitis C virus after living-donor liver transplantation. Transplantation 2004 78 : 1308 1311. (Pubitemid 39507969)
42. Terrault NA. Hepatitis C therapy before and after liver transplantation. Liver Transpl. 2008 14 : S58 66.
43. Ueda Y, Takada Y, Marusawa H et al. Individualized extension of pegylated interferon plus ribavirin therapy for recurrent hepatitis C genotype 1b after living-donor liver transplantation. Transplantation 2010 Jan 27 Epub ahead of print.
44. Terrault NA, Shiffman ML, Lok AS et al. Outcomes in hepatitis C virus-infected recipients of living donor vs. deceased donor liver transplantation. Liver Transpl. 2007 13 : 122 129.
45. Berg CL, Gillespie BW, Merion RM et al. Improvement in survival associated with adult-to-adult living donor liver transplantation. Gastroenterology 2007 133 : 1806 1813.
46. Hashikura Y, Ichida T, Umeshita K et al. Donor complications associated with living donor liver transplantation in Japan. Transplantation 2009 88 : 110 114.
47. Middleton PF, Duffield M, Lynch SV et al. Living donor liver transplantation-adult donor outcomes: recipients: a systematic review. Liver Transpl. 2006 12 : 24 30.
48. Ghobrial RM, Freise CE, Trotter JF et al. Donor morbidity after living donation for liver transplantation. Gastroenterology 2008 135 : 468 476.